Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Retained Earnings (2018 - 2026)

TELA Bio has reported Retained Earnings over the past 8 years, most recently at $91000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.03% year-over-year to $91000.0; the TTM value through Dec 2025 reached $91000.0, up 100.03%, while the annual FY2025 figure was $91000.0, 100.03% up from the prior year.
  • Retained Earnings for Q4 2025 was $91000.0 at TELA Bio, up from -$388.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $262000.0 in Q3 2022 and troughed at -$388.5 million in Q3 2025.
  • A 5-year average of -$120.2 million and a median of -$24000.0 in 2021 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: surged 709.3% in 2022 and later plummeted 5724940.0% in 2023.
  • Year by year, Retained Earnings stood at -$52000.0 in 2021, then skyrocketed by 388.46% to $150000.0 in 2022, then crashed by 39.33% to $91000.0 in 2023, then crashed by 394308.79% to -$358.7 million in 2024, then surged by 100.03% to $91000.0 in 2025.
  • Business Quant data shows Retained Earnings for TELA at $91000.0 in Q4 2025, -$388.5 million in Q3 2025, and $93000.0 in Q2 2025.